J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e145-e152. doi: 10.1016/j.japh.2020.11.020. Epub 2020 Dec 24.
Currently, 13 U.S. jurisdictions allow for pharmacist-prescribed contraception; however, pharmacists' intention to use and ultimate uptake of this patient care opportunity have been variable.
The objectives of this study were to (1) identify student pharmacists' attitudes toward pharmacist-prescribed hormonal contraception (HC), (2) identify student pharmacist perceived barriers regarding pharmacist-prescribed HC, and (3) explore what factors affect student pharmacists' viewpoints.
An anonymous survey was administered using Qualtrics among third-year student pharmacists in a public health course. The survey was developed using the Theory of Planned Behavior (TPB) and previously published literature. TPB was developed to predict an individuals' intention to engage in a behavior at a specific time and place. All responses were anonymous. Survey responses were summarized using descriptive statistics, and Wilcoxon Mann-Whitney test was used to compare differences based on student pharmacist gender and religion.
A total of 67 student pharmacists participated in the survey (response rate 80.7%). Most agreed-strongly agreed (n = 59, 88.1%) that pharmacists are capable of appropriately assessing and selecting HC therapies and believe it should be within a pharmacist's scope of practice (n = 53, 79.1%). Similarly, most agreed-strongly agreed that it is a professional responsibility for pharmacists to provide this service (n = 56, 83.6%). Potential barriers identified included limited access to patient medical records (n = 55, 82.1%), interruption to workflow (n = 51, 76.1%), and concerns for a decrease in well-women examinations (n = 51, 76.1%). Most identified with the Christian faith (n = 45, 67.2%) but said this did not influence their opinions (n = 40, 59.7%). Gender, age, and religion were not found to be associated with student pharmacists' attitudes. However, an increasing number of barriers were negatively associated with their attitudes.
Student pharmacists believe it is within a pharmacist's scope of practice and a professional responsibly to prescribe HC. Student pharmacists were less supportive of pharmacist-prescribed HC if they reported a greater number of barriers.
目前，美国有 13 个司法管辖区允许药剂师开具避孕药；然而，药剂师使用这种患者护理机会的意愿和最终采用率各不相同。
本研究的目的是：(1) 了解实习药剂师对药剂师开具荷尔蒙避孕药 (HC) 的态度，(2) 了解实习药剂师对药剂师开具 HC 的感知障碍，以及 (3) 探讨哪些因素影响实习药剂师的观点。
在公共卫生课程中，使用 Qualtrics 对三年级实习药剂师进行了一项匿名调查。该调查是使用计划行为理论 (TPB) 和以前发表的文献开发的。TPB 旨在预测个人在特定时间和地点从事某种行为的意图。所有回复均为匿名。使用描述性统计对调查回复进行总结，并使用 Wilcoxon Mann-Whitney 检验比较基于实习药剂师性别和宗教的差异。
共有 67 名实习药剂师参与了调查(回复率为 80.7%)。大多数人强烈同意 (n=59，88.1%) 认为药剂师能够恰当地评估和选择 HC 治疗方法，并认为这应该是药剂师实践范围之内的事情 (n=53，79.1%)。同样，大多数人强烈同意，药剂师有责任提供这项服务 (n=56，83.6%)。确定的潜在障碍包括有限的患者病历访问权限 (n=55，82.1%)、工作流程中断 (n=51，76.1%) 以及担心减少妇女健康检查 (n=51，76.1%)。大多数人认同基督教信仰 (n=45，67.2%)，但表示这并没有影响他们的观点 (n=40，59.7%)。性别、年龄和宗教与实习药剂师的态度没有关联。然而，随着障碍数量的增加，他们的态度呈负相关。
实习药剂师认为，在药剂师的实践范围内，为 HC 开处方是其专业责任。如果实习药剂师报告的障碍较多，他们对药剂师开具 HC 的支持度就越低。
Zotero 插件